Johnson & Johnson announces its latest shock wave balloonShockwave E8Approved by the FDA for marketing and fully launched in the United States.Shockwave E8Aimed at optimizing the treatment of patients with calcified femoropopliteal and infrapopliteal peripheral artery disease (PAD), including those with complex chronic limb-threatening ischemia (CLTI).
"The latest peripheral catheter from Shockwave offers significant improvements that will help doctors refine their treatment algorithms and better support challenging patients with severe calcified diseases. The catheter’s ability to treat long lesions and its extended reach allows us to safely and effectively treat some of the most difficult-to-treat patients, including those with CLTI, a complex and severe disease state with high mortality."---Venita Chandra Stanford Health Care"Shockwave E8 represents our commitment to physician-guided innovation while maintaining the simplicity and effectiveness of our IVL technology. We have received very positive feedback from physicians on Shockwave E8 and look forward to establishing it as our new flagship peripheral IVL catheter, enabling physicians to address both above-the-knee and below-the-knee calcium challenges."---Isaac Zacharias, President of Shockwave Medical
Shockwave E8It is a brand-new shock wave balloon catheter, and alsoInShockwave L6、Shockwave S4, Shockwave M5+ Basic Development.Shockwave E8The name is derived from its balloon length (80mm), which is currently the longest lithotripsy balloon, and it contains eight lithotripsy emitters inside the balloon. ThereforeShockwave E8CanTreatment of longer descending aortic lesions (length exceeding 30 cm),Doctors can extend IVL treatment to below-the-knee and very distal lesions.
Shockwave E8Similar to the previous shockwave balloon, the shockwave frequency was 2Hz. A total of 400 pulses were delivered at a pulse rate of 2Hz.
Shockwave E8 Demonstration
Shockwave Medical
ShockWave MedicalIs part of Johnson & Johnson Medical Devices, aiming to improveTreatment Methods for Calcific Cardiovascular Disease.ShockWave MedicalThe goal is to establish a new standard for medical device treatment of cardiovascular calcification diseases through its differentiated and proprietary localized delivery of ultrasound for the treatment of calcified plaques, which they callIntravascular Lithotripsy（“IVL”）。
